Skip to main content

Advertisement

Table 1 Characteristics of men and women ages 67–90 (n = 2571) by quartiles of HOMA-R (Visit 5, 2011–2013)

From: Association of insulin resistance, from mid-life to late-life, with aortic stiffness in late-life: the Atherosclerosis Risk in Communities Study

 HOMA-IROverall
Mean ± SE or n (%)
Quartile 1
Mean ± SE or n (%)
Quartile 2
Mean ± SE or n (%)
Quartile 3
Mean ± SE or n (%)
Quartile 4
Mean ± SE or n (%)
Demographic     
 Age, years75 ± 0.275 ± 0.276 ± 0.275 ± 0.275 ± 0.1
 Men195 (30)235 (37)250 (39)277 (43)957 (37)
 African American88 (14)109 (17)102 (16)134 (21)433 (17)
Anthropometric     
 Waist circumference, cm90 ± 0.495 ± 0.499 ± 0.4103 ± 0.497 ± 0.2
 BMI, kg/m224 ± 0.126 ± 0.128 ± 0.230 ± 0.227 ± 0.1
Hemodynamic     
 SBP, mmHg130 ± 0.7130 ± 0.7131 ± 0.7130 ± 0.6130 ± 0.3
 DBP, mmHg65 ± 0.467 ± 0.466 ± 0.468 ± 0.466 ± 0.2
 MAP, mmHg87 ± 0.588 ± 0.488 ± 0.488 ± 0.488 ± 0.2
 Heart rate, beats per minute62 ± 0.464 ± 0.464 ± 0.465 ± 0.464 ± 0.2
 Blood pressure medication333 (52)378 (59)449 (70)480 (75)1640 (64)
Behavioral     
 Current smoker46 (7)33 (5)39 (6)23 (4)141 (6)
 Current drinker397 (63)368 (59)357 (56)305 (48)1427 (56)
 Former smoker279 (46)295 (50)289 (48)312 (53)1175 (49)
 Former drinker127 (20)131 (21)162 (25)195 (31)615 (24)
cfPWV, cm/s     
 Men1096 ± 211173 ± 191161 ± 181135 ± 171143 ± 9
 Women1089 ± 141103 ± 141117 ± 141147 ± 151112 ± 7
 Overall1091 ± 121129 ± 121134 ± 111142 ± 111124 ± 6
High cfPWV, > 75th percentile     
 Men44 (23)76 (32)68 (27)65 (23)253 (26)
 Women83 (19)95 (23)111 (28)98 (27)387 (24)
 Overall127 (20)171 (27)179 (28)163 (25)640 (25)
  1. Characteristics are defined by either the mean ± standard error or the frequency (percent). For HOMA-IR quartiles, the lower and upper limits are: [0.04, 1.58) for quartile 1; [1.58, 2.41) for quartile 2; [2.41, 3.60) for quartile 3; and [3.60, 9.23] for quartile 4
  2. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, cfPWV carotid-femoral pulse wave velocity, HOMA-IR homeostatic model assessment of insulin resistance